Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E F Lee

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association|March 1, 1986
Autologous bone marrow transplantation after supralethal dose of total body irradiation in a case of mycosis fungoidesY C Chen, C H Wang, S C Huang, et al.
Cell Death & Disease|April 24, 2015
Bid chimeras indicate that most BH3-only proteins can directly activate Bak and Bax, and show no preference for Bak versus BaxC Hockings, K Anwari, R L Ninnis, et al.
Leukemia|July 31, 2009
The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemiaK D Mason, S L Khaw, K C Rayeroux, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Taiwan Yi Xue Hui Za Zhi. Journal of the Formosan Medical Association|March 1, 1986
Autologous bone marrow transplantation after supralethal dose of total body irradiation in a case of mycosis fungoidesY C Chen, C H Wang, S C Huang, et al.
Cell Death & Disease|April 24, 2015
Bid chimeras indicate that most BH3-only proteins can directly activate Bak and Bax, and show no preference for Bak versus BaxC Hockings, K Anwari, R L Ninnis, et al.
Leukemia|July 31, 2009
The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemiaK D Mason, S L Khaw, K C Rayeroux, et al.
Pageof 3